相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
Hokyou Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review
Bertrand Cariou et al.
DIABETES OBESITY & METABOLISM (2021)
MAFLD and risk of CKD
Dan-Qin Sun et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome
Haiyan Yang et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study
Yu-ling Chen et al.
BMC GASTROENTEROLOGY (2021)
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
Donghee Kim et al.
JOURNAL OF HEPATOLOGY (2021)
Prolactin, metabolic and immune parameters in naive subjects with a first episode of psychosis
Clemente Garcia-Rizo et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?-Results From NHANES III
Qi Huang et al.
FRONTIERS IN MEDICINE (2021)
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes
Rosa Lombardi et al.
LIVER INTERNATIONAL (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
Angeliki Katsarou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
The Association Between Prolactin and Metabolic Parameters in PCOS Women: A Retrospective Analysis
Haiyan Yang et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin et al.
LIVER INTERNATIONAL (2020)
Glucose-Lipid Metabolism in Obesity with Elevated Prolactin Levels and Alteration of Prolactin Levels After Laparoscopic Sleeve Gastrectomy
Xingchun Wang et al.
OBESITY SURGERY (2020)
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Sakura Yamamura et al.
LIVER INTERNATIONAL (2020)
The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor
Xiaofu Zhang et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans
Antonio J. Ponce et al.
ENDOCRINE (2020)
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Peter J. Eddowes et al.
GASTROENTEROLOGY (2019)
Prolactin - a pleiotropic factor in health and disease
Valerie Bernard et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Pituitary Hyperplasia from Primary Hypothyroidism
K. S. Shivaprasad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Glucose Abnormalities Associated to Prolactin Secreting Pituitary Adenomas
Renata S. Auriemma et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Chanbin Lee et al.
CELLS (2019)
Ablation of prolactin receptor increases hepatic triglyceride accumulation
Shanshan Shao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
The value of prolactin in predicting prolactinma in hyperprolactinaemic polycystic ovarian syndrome
Eleni Magdalini Kyritsi et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2018)
Prolactin improves hepatic steatosis via CD36 pathway
Pengzi Zhang et al.
JOURNAL OF HEPATOLOGY (2018)
Circulating prolactin concentrations and risk of type 2 diabetes in US women
Jun Li et al.
DIABETOLOGIA (2018)
The effects of hyperprolactinemia and its control on metabolic diseases
Renata S. Auriemma et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2018)
Prolactin Promotes Adipose Tissue Fitness and Insulin Sensitivity in Obese Males
Xarubet Ruiz-Herrera et al.
ENDOCRINOLOGY (2017)
Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis
Joan C. Lo et al.
HEMODIALYSIS INTERNATIONAL (2017)
Insight into the Endocrine System and the Immune System: A Review of the Inflammatory Role of Prolactin in Rheumatoid Arthritis and Psoriatic Arthritis
Man W. Tang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Circulating Prolactin and Risk of Type 2 Diabetes: A Prospective Study
Tiange Wang et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Gestational Diabetes Mellitus From Inactivation of Prolactin Receptor and MafB in Islet β-Cells
Ronadip R. Banerjee et al.
DIABETES (2016)
Nonalcoholic Fatty Liver Disease The New Complication of Type 2 Diabetes Mellitus
Fernando Bril et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2016)
A Longer Duration of Estrogen Deficiency Increases Fibrosis Risk Among Postmenopausal Women With Nonalcoholic Fatty Liver Disease
Jagpal Singh Klair et al.
HEPATOLOGY (2016)
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
Stefano Ballestri et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
New insights in prolactin: pathological implications
Valerie Bernard et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality
Robin Haring et al.
EUROPEAN HEART JOURNAL (2014)
Circulating Prolactin Associates With Diabetes and Impaired Glucose Regulation A population-based study
Tiange Wang et al.
DIABETES CARE (2013)
A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease
Sunmi Kim et al.
BMC GASTROENTEROLOGY (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Serum prolactin concentrations determine whether they improve or impair β-cell function and insulin sensitivity in diabetic rats
Sunmin Park et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease
Yuichiro Eguchi et al.
JOURNAL OF GASTROENTEROLOGY (2006)
The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy
O Serri et al.
CLINICAL ENDOCRINOLOGY (2006)
Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells
T Itagaki et al.
GUT (2005)
Prolactin: structure, function, and regulation of secretion
ME Freeman et al.
PHYSIOLOGICAL REVIEWS (2000)
分享论文
